LORD, ABBETT & CO. LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 213 filers reported holding IMMUNOMEDICS INC in Q4 2018. The put-call ratio across all filers is 1.36 and the average weighting 0.6%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$7,565,000
-93.5%
88,966
-97.3%
0.02%
-94.1%
Q2 2020$117,177,000
+1384.8%
3,306,343
+497.8%
0.41%
+1313.8%
Q4 2018$7,892,000
-66.1%
553,055
-50.5%
0.03%
-55.4%
Q3 2018$23,278,000
-31.8%
1,117,518
-22.4%
0.06%
-35.0%
Q2 2018$34,108,000
+149.6%
1,440,959
+54.1%
0.10%
+143.9%
Q1 2018$13,665,000
-9.8%
935,328
-0.3%
0.04%
-4.7%
Q4 2017$15,156,000
-4.2%
937,890
-17.1%
0.04%
-6.5%
Q3 2017$15,815,000
+49.6%
1,131,284
-5.5%
0.05%
+48.4%
Q2 2017$10,570,0001,197,0830.03%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders